AVEO Insider Trading Activity and SEC Form 4 Filings
AVEO insider trading summary
No open-market insider purchases or sales of Aveo Pharmaceuticals, Inc. (AVEO) have been reported on SEC Form 4 in the past 12 months.
Latest AVEO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 1, 2021 | Michael P Bailey | President & CEO | Buy | $97K (15,000 @ $6.48) |
| Aug 10, 2021 | Michael Ferraresso | Chief Commercial Officer | Buy | $15K (2,608 @ $5.75) |
| Jun 19, 2020 | Anthony A. Florence Jr. | 10% Owner | Buy | $7.5M (1,428,571 @ $5.25) |
| Jun 19, 2020 | Forest Baskett | 10% Owner | Buy | $7.5M (1,428,571 @ $5.25) |
| Jun 19, 2020 | Growth Equity Opportunities Fund IV, LLC | 10% Owner | Buy | $7.5M (1,428,571 @ $5.25) |
| Jun 19, 2020 | Nea 15 Gp, LLC | 10% Owner | Buy | $7.5M (1,428,571 @ $5.25) |
| Jun 19, 2020 | Joshua Makower | 10% Owner | Buy | $7.5M (1,428,571 @ $5.25) |
| Jun 19, 2020 | Peter W. Sonsini | 10% Owner | Buy | $7.5M (1,428,571 @ $5.25) |
| Jun 19, 2020 | Scott D Sandell | 10% Owner | Buy | $7.5M (1,428,571 @ $5.25) |
| Jun 19, 2020 | New Enterprise Associates 15, L.P. | 10% Owner | Buy | $7.5M (1,428,571 @ $5.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.